Eric Shiozaki

Eric is a Partner at DCVC Bio, a life science venture capital firm. Previously, he was a Partner at Novo Ventures where he helped establish and managed the firm’s public equities strategy focused on smidcap and late-stage private companies in biotech and medtech. Earlier in his career he was a Director at Apposite Capital after starting his investment career as an Associate at Burrill & Company. Eric received a B.S. in Biophysics from Johns Hopkins University and a Ph.D. in Molecular Biology from Princeton University.